GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » FCF Yield %

Stealth BioTherapeutics (Stealth BioTherapeutics) FCF Yield % : 0.00 (As of May. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Stealth BioTherapeutics's Trailing 12-Month Free Cash Flow is $-45.04 Mil, and Market Cap is $23.54 Mil. Therefore, Stealth BioTherapeutics's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Stealth BioTherapeutics's FCF Yield % or its related term are showing as below:


MITO's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.53
* Ranked among companies with meaningful FCF Yield % only.

Stealth BioTherapeutics's FCF Margin % for the quarter that ended in Mar. 2022 was 0.00%.


Stealth BioTherapeutics FCF Yield % Historical Data

The historical data trend for Stealth BioTherapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics FCF Yield % Chart

Stealth BioTherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
FCF Yield %
Get a 7-Day Free Trial - - -40.55 -67.71 -91.44

Stealth BioTherapeutics Quarterly Data
Dec16 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stealth BioTherapeutics's FCF Yield %

For the Biotechnology subindustry, Stealth BioTherapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stealth BioTherapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's FCF Yield % falls into.



Stealth BioTherapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Stealth BioTherapeutics's FCF Yield % for the fiscal year that ended in Dec. 2021 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-45.038 / 49.255686
=-91.44%

Stealth BioTherapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 42.01540236
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stealth BioTherapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Stealth BioTherapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005
Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.

Stealth BioTherapeutics (Stealth BioTherapeutics) Headlines

From GuruFocus